Annual Hall of Fame Luncheon Benefits Student Scholarship Fund Join us for Podiatry Management's Annual Hall of Fame luncheon honoring Hal Ornstein, DPM, and John R. Carson, former APMA Director of Legislative Advocacy.
The Hall of Fame luncheon will take place at noon, Friday, July 31, 2009, at the Toronto Convention Center.
Individual tickets are $50; a table of 10 is $500. You can register for the luncheon when you register for the National 2009 or by using registration forms included in APMA News. Tickets can also be purchased and picked up on site at the APMA booth, which will be located in the exhibit hall.
All ticket sale proceeds will benefit the APMA Educational Foundation Student Scholarship Fund.
If you have any questions, please contact Foundation Coordinator Sandra F. Arez at 1-800-ASK-APMA, ext. 244, or at firstname.lastname@example.org.
FDA Warns of Serious Adverse Event in Patients Taking Raptiva
FDA issued a Public Health Advisory to notify healthcare professionals of three confirmed and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, in patients using the psoriasis drug Raptiva. In October 2008, the labeling for Raptiva was changed to highlight, in a boxed warning, the risks of life-threatening infections, including PML. In addition, FDA directed Genentech, the manufacturer of Raptiva, to develop a Risk Evaluation and Mitigation Strategy, or REMS, to ensure that patients receive risk information about Raptiva. The FDA is reviewing this latest information. The agency will take appropriate steps to ensure that the risks of Raptiva do not outweigh its benefits, that patients prescribed Raptiva are clearly informed of the signs and symptoms of PML, and that healthcare professionals carefully monitor patients for the possible development of PML. The Public Health Advisory provides recommendations for healthcare providers and patients when treatment with this product is considered.
Read the MedWatch safety summary, including links to the Public Health Advisory and News Release here.
Limb Salvage at University of Arizona
Recently APMA and representatives of the Society for Vascular Surgery (SVS) met to begin exploring ways in which our respective organizations can work collaboratively to care for our patients, especially those with diabetes (eNews 2,756). APMA member David G. Armstrong, DPM, PhD, professor of surgery and director of the University of Arizona College of Medicine's Southern Arizona Limb Salvage Alliance (SALSA) was present on APMA's behalf. He was joined by his colleague and SALSA partner Joseph L. Mills, MD, professor and chief of vascular and endovascular surgery at the University of Arizona Health Sciences Center.
The following video illustrates how Dr. Armstrong and others at SALSA are treating patients with foot wounds to help prevent unnecessary amputations. View the video here.
Dr. Armstrong sits on the Journal of the American Medical Association (JAPMA) editorial advisory board, acts as a Clinical Practice Advisory Committee (CPAC) diabetes advisor, and is an APMA annual meeting faculty member.
Information in the APMA Daily eNews is intended for APMA members and is not a substitute for professional legal, financial, or medical advice-coding rules and payment policies in particular can vary from carrier to carrier. If you do not wish to receive the APMA Daily eNews, please inform the Association by replying to this message. For a free subscription or to change your e-mail address in APMA's database, please write to email@example.com. Previous editions of the APMA Daily eNews are available at www.apma.org/DailyeNews (members may log in by using their APMA member number as the username, and their case-sensitive last name for the password).